An interventional study of Sustained Isometric Handgrip Exercise and Semi-Supine Bicycle Exercise in Heart Failure, sponsored by Norwegian University of Science and Technology. Not yet recruiting at 1 site in Norway. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 104 studies in Heart Failure with a site in Norway — 16 open to participants now, 19 under way, 1 of them phase 3. Heart Failure · Norway.
Among the 104 studies in Heart Failure with a site in Norway, this one is the 75th largest by planned enrollment of the 83 interventional ones that give a count, is one of 6 that started in 2026, is one of 40 with no phase, reaches primary completion later than 5 of the 18 other live ones, and was the 103rd registered.
6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.
Browse Heart Failure studies →16 of the 104 studies in Heart Failure with a site in Norway are open now. Recruiting first, the newest first:
Oslo University Hospital · Sites in Norway, United States, Belgium and 7 more countries
Ages 18+
Rigshospitalet, Denmark · Sites in Norway, Denmark, Finland and 1 more country
Ages 18–99
Skane University Hospital · Sites in Norway, Sweden
Ages 18+
Bayer · Sites in Norway, Austria, Belgium and 14 more countries
Ages 18+
University Hospital of North Norway · Sites in Norway
Ages 40+ · Healthy volunteers
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
104 studies; the count open now beside each. This study's row is marked.
First in 1983; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 25 is below the median of 76 across 4,053 interventional studies indexed under Heart Failure.
Median enrollment 270 across the 83 interventional studies, 200 across the 21 observational. Of the 75 that completed or were terminated, 28 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
47 of 104 have an industry lead sponsor. The 10 most frequent:
Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 47 are open to participants now.
Norwegian University of Science and Technology has 7 studies filed under Heart Failure — fewer than ten, so there is no comparison to draw.
1 of the studies in Heart Failure with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07850726Norwegian University of Science and TechnologyDeep Learning-Based Automated Pressure-Strain Loop Analysis | 2027-05 |
Add it to your calendar (.ics) → With an account.
Among the 104 studies in Heart Failure with a site in Norway, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Noninvasive left ventricular pressure-strain loop analysis estimates myocardial work from longitudinal strain, brachial systolic blood pressure, and cardiac valve-event timing. It provides global work index, constructive work, wasted work, and work efficiency.
This study evaluates a deep-learning method that automates myocardial work and loop-shape analysis. The method may reduce analysis time, improve reproducibility, and identify patterns associated with heart failure.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Heart failure participants:
Healthy volunteers:
Exclusion Criteria:
Heart failure participants:
Healthy volunteers:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants undergo echocardiography at rest, during sustained handgrip, and during semi-supine bicycle exercise.
Behavioral: Sustained Isometric Handgrip Exercise · Behavioral: Semi-Supine Bicycle Exercise
Healthy volunteers undergo echocardiography at rest, during sustained handgrip, and during semi-supine bicycle exercise.
Behavioral: Sustained Isometric Handgrip Exercise · Behavioral: Semi-Supine Bicycle Exercise
Participants perform sustained isometric handgrip at around 30 % of maximal voluntary contraction for 5 minutes during echocardiography.
Participants perform graded semi-supine bicycle exercise during echocardiography.
Echocardiographic Acquisition Success
Percentage of acquired examinations successfully processed by the deep-learning pipeline to generate myocardial work indices, assessed separately at rest, during handgrip, and during bicycle exercise.
Time frame: During one study visit: at rest, during the handgrip and bicycle test.
Agreement Between Deep Learning- and Expert-Derived Myocardial Work Indices
Agreement for myocardial work indices will be assessed using mean bias with 95% limits of agreement, and mean absolute error.
Time frame: Echocardiograms acquired at rest and during handgrip and bicycle exercise at a single study visit.
Plan to share: No — Individual participant data sharing is not currently planned. Any future sharing would require appropriate ethical, institutional, and data-protection approvals.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for May 2027, 8 months later.
Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 8 months is below that.
Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology →